FNDC5 and renal osteodystrophy: Our work reveals the therapeutic potential of irisin in renal osteodystrophy and provides the conceptual basis for sustained irisin therapy and combination therapy of irisin and conventional antiresorptive drugs in the management of renal osteodystrophy.